BackgroundCheck.run
Search For

Xiaoming Ming Zhang, 62Belmont, MA

Xiaoming Zhang Phones & Addresses

Belmont, MA   

Edison, NJ   

Decatur, GA   

San Jose, CA   

Evanston, IL   

Chicago, IL   

Fremont, CA   

Work

Company: Cleveland clinic Oct 2012 Position: Research scientist

Education

School / High School: City University of New York Oct 2005 Specialities: PhD in Chemistry

Mentions for Xiaoming Ming Zhang

Career records & work history

License Records

Xiaoming Zhang

Address:
San Jose, CA 95117
Licenses:
License #: 29705 - Active
Issued Date: Nov 8, 2012
Expiration Date: Jun 30, 2018
Type: Certified Public Accountant

Xiaoming Zhang resumes & CV records

Resumes

Xiaoming Zhang Photo 30

Owner

Industry:
Alternative Medicine
Work:
Ac Health Center
Owner
Education:
Harbin Medical University 1977 - 1982
Xiaoming Zhang Photo 31

Xiaoming Zhang

Xiaoming Zhang Photo 32

Xiaoming Zhang

Xiaoming Zhang Photo 33

Xiaoming Zhang

Xiaoming Zhang Photo 34

Xiaoming Zhang

Xiaoming Zhang Photo 35

Xiaoming Zhang - Avon, OH

Work:
Cleveland Clinic Oct 2012 to 2000
Research Scientist
Coyahoga community college Sep 2011 to 2000
Instructor
Louis Stokes VA Medical Center Sep 2008 to 2000
Research Scientist
Procter and Gamble Co - Cincinnati, OH Dec 2007 to Aug 2008
Chemist
University of California at Davis - Davis, CA Jan 2006 to Jul 2007
Postdoctoral Associate
City University of New York - New York, NY Jan 2000 to Oct 2005
Research Assistant
University of Science and Technology of China - Hefei, CN Sep 1996 to Jul 1999
Research Assistant
General Chemistry, Univ 1996 to 1997
Sci. & Tech. of China, China
Education:
City University of New York Oct 2005
PhD in Chemistry
City University of New York Jun 2002
M.S. in Chemistry
University of Science and Technology of China Jun 1996
B.S. in Chemistry

Publications & IP owners

Us Patents

Imidazolinyimethyl Aralklsulfonamides

US Patent:
6756395, Jun 29, 2004
Filed:
Apr 22, 2003
Appl. No.:
10/421119
Inventors:
Michael Patrick Dillon - San Carlos CA
Clara Jeou Jen Lin - Palo Alto CA
Counde OYang - Sunnyvale CA
Xiaoming Zhang - Campbell CA
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A61K 314178
US Classification:
514402, 514401, 5483551, 5483491, 5483114
Abstract:
Compounds of the Formula: where R -R are those defined herein and methods for producing the same. Also provided are pharmaceutical compositions comprising a Compound of Formula I and methods for their use as therapeutic agents.

5-Ht3 Receptor Antagonists And Methods Of Use

US Patent:
6770655, Aug 3, 2004
Filed:
Jan 21, 2003
Appl. No.:
10/348669
Inventors:
Xiaoming Zhang - Campbell CA
Jurg R. Pfister - Los Altos CA
Cyrus Becker - Menlo Park CA
Pascal Druzgala - Santa Rosa CA
Assignee:
Aryx Therapeutics - Santa Clara CA
International Classification:
A61K 31437
US Classification:
514292, 514397, 546 86, 5483114
Abstract:
The subject invention provides useful and novel 5-HT3 antagonists. The subject invention also provides methods for synthesizing the compounds of invention. The invention also provides methods for the treatment of irritable bowel syndrome and other such conditions.

Quinazolone Derivatives As Alpha 1A/B Adrenergic Receptor Antagonists

US Patent:
6900220, May 31, 2005
Filed:
Jan 2, 2002
Appl. No.:
10/040319
Inventors:
Cyrus Kephra Becker - Menlo Park CA, US
Joan Marie Caroon - Mountain View CA, US
Chris Richard Melville - Palo Alto CA, US
Fernando Padilla - Fremont CA, US
Jürg Roland Pfister - Los Altos CA, US
Xiaoming Zhang - Campbell CA, US
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
A61K031/517
A61K031/535
C07D487/00
C07D417/00
C07D471/00
US Classification:
51426621, 5142342, 5142345, 514249, 51425217, 5142641, 5142662, 544116, 544117, 544279, 544284, 544350
Abstract:
This invention relates to compounds which are generally alpha-1A/B adrenoceptor antagonists and which are represented by Formula I: wherein Z is —C(O)— or —S(O)—, X is carbon or nitrogen, Y is carbon, and X—Y considered together are two adjoining atoms of the ring A, said ring being a fused aromatic ring of five to six atoms per ring optionally incorporating one to two heteroatoms per ring, chosen from N, O, or S; and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.

Quinazolone Derivatives As Alpha 1A/B Adrenergic Receptor Antagonists

US Patent:
7091200, Aug 15, 2006
Filed:
Oct 22, 2004
Appl. No.:
10/971522
Inventors:
Cyrus Kephra Becker - Menlo Park CA, US
Joan Marie Caroon - Mountain View CA, US
Chris Richard Melville - Palo Alto CA, US
Fernando Padilla - Fremont CA, US
Jürg Roland Pfister - Los Altos CA, US
Xiaoming Zhang - Campbell CA, US
Assignee:
Syntex U.S.A. LLC - Palo Alto CA
International Classification:
A61K 31/54
A61P 13/08
C07D 285/22
A61K 31/549
A61K 31/517
A61K 31/519
C07D 487/04
C07D 241/36
C07D 471/02
US Classification:
5142232, 5142591, 51426621, 544 12, 544 13, 544281, 544284
Abstract:
This invention relates to compounds which are generally alpha-1A/B adrenoceptor antagonists and which are represented by Formula I:.

5-Ht3 Receptor Antagonists And Methods Of Use

US Patent:
7125886, Oct 24, 2006
Filed:
May 28, 2004
Appl. No.:
10/857108
Inventors:
Xiaoming Zhang - Campbell CA, US
Jurg R. Pfister - Los Altos CA, US
Cyrus Becker - Menlo Park CA, US
Pascal Druzgala - Santa Rosa CA, US
Assignee:
Aryx Therapeutics - Fremont CA
International Classification:
A01N 43/42
A61K 31/44
C07D 471/00
C07D 491/00
C07D 515/00
US Classification:
514292, 514397, 546 86, 5483117
Abstract:
The subject invention provides useful and novel 5-HT3 antagonists. The subject invention also provides methods for synthesizing the compounds of invention. The invention also provides methods for the treatment of irritable bowel syndrome and other such conditions.

Imidazolinylmethyl Aralkylsulfonamides

US Patent:
7407980, Aug 5, 2008
Filed:
Apr 13, 2004
Appl. No.:
10/823012
Inventors:
Michael Patrick Dillon - San Carlos CA, US
Clara Jeou Jen Lin - Palo Alto CA, US
Counde O'Yang - Sunnyvale CA, US
Xiaoming Zhang - Campbell CA, US
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A61K 31/4174
C07D 233/24
US Classification:
514401, 5483551
Abstract:
Compounds of the Formula:.

5-Ht3 Receptor Antagonists And Methods Of Use

US Patent:
7501436, Mar 10, 2009
Filed:
Oct 20, 2006
Appl. No.:
11/551562
Inventors:
Xiaoming Zhang - Sunnyvale CA, US
Jurg R. Pfister - Los Altos CA, US
Cyrus Becker - Fremont CA, US
Pascal Druzgala - Santa Rosa CA, US
Assignee:
ARYx Therapeutics, Inc. - Fremont CA
International Classification:
A01N 43/42
A61K 31/44
US Classification:
514292
Abstract:
The subject invention provides useful and novel 5-HT3 antagonists. The subject invention also provides methods for synthesizing the compounds of invention. The invention also provides methods for the treatment of irritable bowel syndrome and other such conditions.

4-Substituted Quinuclidine Derivatives, Methods Of Production, Pharmaceutical Uses Thereof

US Patent:
8114891, Feb 14, 2012
Filed:
Sep 30, 2008
Appl. No.:
12/242389
Inventors:
Jürg R. Pfister - Los Altos CA, US
Meenakshi S. Venkatraman - Fremont CA, US
Xiaoming Zhang - Sunnyvale CA, US
Assignee:
CoMentis, Inc. - South San Francisco CA
International Classification:
A61K 31/439
C07D 401/12
US Classification:
514305, 546196
Abstract:
The present invention relates to compounds and formulations capable of affecting nicotinic acetylcholine receptors (nAChRs), for example, as modulators of specific nicotinic receptor subtypes (specifically, the alpha7 nAChR subtype). The present invention also relates to methods for treating a wide variety of conditions and disorders, particularly those associated with dysfunction of the central and autonomic nervous systems.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.